Agenda: Workshop on Assessing and Improving the Value of Cancer Care
NAS Lecture Room
National Academy of Sciences Building
2100 C Street, NW Washington, DC
Meeting Agenda
DAY ONE - Breakfast at 7:30 am
8:00 am Welcome, Introductory Remarks: What is Value in Cancer Care? Why is it Important?
Scott Ramsey, Fred Hutchinson Cancer Research Center
8:20 am Physician – Patient Communication and its Influence on Value
Moderator: Allen Lichter, ASCO
8:25 Therapy for Cancer: Inside the Physician-Patient Discussion
Speaker: Tony Back, University of Washington
8:55 Discussion
9:10 Can We Communicate Effectively with Cancer Patients about the Benefits and Risks of Cancer Treatments?
Speaker: Peter Ubel, University of Michigan
9:40 Discussion
9:55 Therapy for Advanced Stage Cancer: What Do Patients Want and Expect?
Speaker: Robert Erwin, Marti Nelson Foundation
10:25 Discussion
10:40 Ten Minute Break
10:50 am Generating Evidence about Effectiveness and Value
Moderator: Steve Cohen, AHRQ
10:55 FDA Perspectives on Evidence for Regulatory Approval in Cancer
Speaker: Janet Woodcock, FDA
11:25 Discussion
11:40 What Constitutes Reasonable Evidence of Efficacy and Effectiveness?
Speaker: Dan Sargent, Mayo Clinic
12:10 Discussion
12:25 Lunch
1:00 pm Value and the Oncology Market
Moderator: Jeff Lerner, ECRI
1:05 Drug Pricing and Value in Oncology vs. Other Areas in Medicine
Speaker: Patricia Danzon, Wharton School, University of Pennsylvania
1:35 Discussion
1:50 Industry Perspective on Pharmaceutical Pricing in Oncology
Speaker: Greg Rossi, Genentech
2:20 Discussion
2:35 Evolution of Therapy for Cancer: Cost Implications
Speaker: Deborah Schrag, Dana Farber/Harvard Cancer Center
2:50 Discussion
3:20 Ten Minute Break
3:30 pm Value in Cancer Practice: Health Insurer Perspectives
Moderator: Scott Ramsey, Fred Hutchinson Cancer Research Center
3:35 Oncologists’ Perception of Value in Oncology
Speaker: Peter Neumann, Institute for Clinical Research and Health Policy Studies, Tufts
4:05 Discussion
4:20 Paying for New Cancer Treatments: Rights and Responsibilities of Health Insurers
Speaker: Lee Newcomer, United Healthcare
4:50 Discussion
5:05 European Experience and Perspectives on Evaluating Value for Oncology Products
Speaker: Michael Drummond, UK National Institute for Clinical Excellence
5:35 Discussion
5:50 Adjourn for the Day
DAY TWO - Breakfast at 7:30 am
8:00 am Ethical Issues for Value Based Decision Making in Oncology
Moderator: Harold Moses, Vanderbilt-Ingram Cancer Center
8:05 Ethical Issues when Considering Insurance Coverage Based on Value in the Treatment of Cancer
Speaker: Daniel Brock, Harvard Medical School
8:35 Discussion
8:50 Patient-Physician Communication on Therapy Options for Cancer: Ethical Issues
Speaker: Neil Wenger, University of California, Los Angeles
9:20 Discussion
9:35 10 Minute Break
9:45 am Improving Value in Oncology Practice: Ways Forward
Moderator: Lou Garrison, University of Washington
9:50 Value Based Insurance Design- Initiatives Outside of Oncology
Speaker: Michael Chernew, Harvard Medical School
10:20 Discussion
10:35 Generating Evidence of Value Post-FDA Approval: is there a Role for Health Insurers?
Speaker: Sean Tunis, Center for Medical Technology Policy
11:05 Discussion
11:20 Are there Ways to Improve the Value of Cancer Care that May Work at the Bedside?
Speaker: Thomas Smith, Virginia Commonwealth University
11:50 Discussion
12:05 10 Minutes to Retrieve Prepared Lunch. Please Return for a Working Lunch with the Last Session.
Working Lunch
12:15 pm Toward a Shared Understanding of Value: Can We Agree & Does Perspective Matter?
Moderator: Peter Bach, Memorial Sloan-Kettering Cancer Center
Panel: All Moderators
1:30 Meeting Adjourns
Back to Meeting